We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQHA.WS
951
CALL
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$4.1M 0.02%
+424,015
New +$240K
SYNH
952
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$4.09M 0.02%
+45,732
New +$3.86M
CLF icon
953
PUT
Cleveland-Cliffs
CLF
$6.81B
$4.08M 0.02%
189,300
+177,500
+1,504% +$3.5M
CSTA.WS
954
CALL
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$4.08M 0.02%
416,663
KIM icon
955
Kimco Realty
KIM
$17.6B
$4.08M 0.02%
+195,523
New +$4.06M
SCPE
956
DELISTED
SC Health Corporation
SCPE
$4.07M 0.02%
403,448
DOO
957
Bombardier Recreational Products
DOO
$4.43B
$4.06M 0.02%
51,846
-33,784
-39% -$2.86M
MPLN.WS
958
CALL
DELISTED
MultiPlan Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MPLN.WS
$4.05M 0.02%
424,997
+150,000
+55% +$244K
TRIL
959
DELISTED
Trillium Therapeutics Inc.
TRIL
$4.04M 0.02%
416,924
+19,979
+5% +$188K
CZR icon
960
Caesars Entertainment
CZR
$6.1B
$4.04M 0.02%
+38,951
New +$3.93M
MSFT icon
961
PUT
Microsoft
MSFT
$2.84T
$4.04M 0.02%
14,900
+4,000
+37% +$1.02M
SWETW
962
CALL
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$4.04M 0.02%
+416,869
New +$274K
VRSK icon
963
Verisk Analytics
VRSK
$26.4B
$4.03M 0.02%
23,057
-11,947
-34% -$2.12M
PLTK icon
964
Playtika
PLTK
$1.4B
$4.02M 0.02%
+168,783
New +$4.41M
HON icon
965
Honeywell
HON
$77.1B
$4.02M 0.02%
19,449
-76,643
-80% -$16.2M
DDD icon
966
3D Systems Corp
DDD
$420M
$4.02M 0.02%
100,504
+73,445
+271% +$1.94M
GIWWU
967
DELISTED
GigInternational1, Inc. Units
GIWWU
$4.02M 0.02%
+400,000
New +$4.01M
UWMC.WS
968
CALL
DELISTED
UWM Holdings Warrants
UWMC.WS
$4.01M 0.02%
474,997
+93,378
+24% +$160K
MACC.WS
969
CALL
DELISTED
Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
MACC.WS
$4.01M 0.02%
+412,719
New +$271K
SFTW.WS
970
CALL
DELISTED
Osprey Technology Acquisition Corp. Redeemable Warrants, each whole Warrant exercisable for one shar
SFTW.WS
$4M 0.02%
400,589
+150,590
+60% +$215K
O icon
971
Realty Income
O
$61.2B
$4M 0.02%
61,841
-127,610
-67% -$8.38M
PDAC
972
DELISTED
Peridot Acquisition Corp.
PDAC
$4M 0.02%
328,161
+2,333
+0.7% +$25.1K
SNTI icon
973
Senti Biosciences Holdings
SNTI
$12.6M
$3.98M 0.02%
+40,000
New +$3.99M
ZBH icon
974
Zimmer Biomet
ZBH
$17.7B
$3.97M 0.02%
25,409
-61,212
-71% -$9.92M
OACB
975
DELISTED
Oaktree Acquisition Corp. II
OACB
$3.95M 0.02%
399,984

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.